Global veterinary organizations issue joint statement against antimicrobial resistance

Europe, Canada, and the United States team up in an effort to make a change internationally

Suggested Veterinary Products

The Canadian Veterinary Medical Association (CVMA) is one of three global organizations working together to fight against antimicrobial resistance.

Veterinary organizations in Europe and the United States have issued a joint statement with the CVMA to ensure oversight of antimicrobial use, mitigation of antimicrobial resistance, and the continuing availability of critical animal and human medications.

The Joint Statement on Continuous Monitoring of Antimicrobial Use and Antimicrobial Resistance describes strategies to preserve the effectiveness and availability of antimicrobial drugs and safeguard animal welfare, public health, and the environment.

“As veterinarians, we oversee the appropriate and responsible use of antimicrobials in animals, thereby helping minimize the emergence and spread of antimicrobial resistance,” said CVMA president Terri Chotowetz, DVM, BSA.

“By working together, we are demonstrating our professional responsibility in supporting the overarching international strategy on antimicrobial resistance and use.”

Some recommendations included in the AVMA, Federation of Veterinarians of Europe (FVE), and CVMA’s statement are:

  • Veterinarians must retain access to effective antimicrobials for therapeutic purposes for animals suffering from a bacterial disease.
  • Medically or critically important antimicrobials should only be administered to animals with the oversight of a licensed veterinarian.
  • Record keeping is essential at the patient or practice level to evaluate antimicrobial treatments.
  • In addition to evaluating individual cases, there also is a need to monitor the overall use of antimicrobials with both companion animals and food production.
  • A global network should be established for surveillance and monitoring of antimicrobial use and resistance.
  • Easily accessible, effective, rapid, and standardized diagnostic susceptibility tests should be available and their results should be available to facilitate evidence-based decisions about antimicrobials.


Leave a Comment


Your email address will not be published. Required fields are marked *